CoChat

How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication

Open access
Groot, Peter C., van Os, Jim · 2020 · Therapeutic Advances in Psychopharmacology

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Coming off psychotropic drugs can cause physical as well as mental withdrawal, resulting in failed withdrawal attempts and unnecessary long-term drug use. The first reports about withdrawal appeared in the 1950s, but although patients have been complaining about psychotropic withdrawal problems for decades, the first tentative acknowledgement by psychiatry only came in 1997 with the introduction of the ‘antidepressant-discontinuation syndrome’. It was not until 2019 that the UK Royal College of Psychiatrists, for the first time, acknowledged that withdrawal can be severe and persistent. Given the lack of a systematic professional response, over the years, patients who were experiencing withdrawal started to work out practical ways to safely come off medications themselves. This resulted in an experience-based knowledge base about withdrawal which ultimately, in The Netherlands, gave rise to the development of person-specific tapering medication (so-called tapering strips). Tapering medication enables doctors, for the first time, to flexibly prescribe and adapt the medication required for responsible and person-specific tapering, based on shared decision making and in full agreement with recommendations in existing guidelines. Looking back, it is obvious that the simple practical solution of tapering strips could have been introduced much earlier, and that the traditional academic strategy of comparisons from randomised trials is not the logical first step to help individual patients. While randomised controlled trials (RCTs) are the gold standard for evaluating interventions, they are unable to accommodate the heterogeneity of individual responses. Thus, a more individualised approach, building on RCT knowledge, is required. We propose a roadmap for a more productive way forward, in which patients and academic psychiatry work together to improve the recognition and person-specific management of psychotropic drug withdrawal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2045125320932452

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. How many patients suffer from withdrawal? The histogram shows the duration of successful tapers for 810 patients who successfully tapered venlafaxine from the lowest available registered dose of 37.5 mg to zero. The duration of the taper is used as a proxy for the severity of experienced withdrawal (see main text).
Figure 1. How many patients suffer from withdrawal? The histogram shows the duration of successful tapers for 810 patients who successfully tapered venlafaxine from the lowest available registered dose of 37.5 mg to zero. The duration of the taper is used as a proxy for the severity of experienced withdrawal (see main text).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 8

  1. Selikoff IJ, 1953, Am Rev Tuberc, 67, 212
  2. Schatzberg AF, 1997, J Clin Psychiatry, 58, 23
  3. Eveleigh R, 2017, BJGP Open, 1
  4. Groot PC, 2013, Tijdschr Psychiatr, 55, 789
  5. Scoping about tapering of (specific) antidepressants using tapering strips, Organized by the Dutch National Healthcare Institute
  6. 10.1177/0269881107081550 · doi:10.1177/0269881107081550 · Paper page
  7. Schatzberg AF, 2006, J Clin Psychiatry, 67, 27
  8. Muzina DJ., 2010, Currenty Psychiatry, 9, 51

Cited by

See all 49

Metadata

Authors
Groot, P. C., & van Os, J.
Affiliations
  • University Medical Center Utrecht (NL)
  • UMC Utrecht Brain Centre, Utrecht, The Netherlands
Corresponding author
Groot, Peter C.
Venue
Therapeutic Advances in Psychopharmacology
Published
2020-01
Volume
10
Pages
2045125320932452-2045125320932452
ISSN
  • 2045-1253 (ISSN-L)
  • 2045-1261
OpenAlex
W3040943896
Cited by
49
References
46
Citations by year
2026: 4 · 2025: 5 · 2024: 13 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 5
FWCI
0.89
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
antidepressant discontinuation syndrome, shared decision-making, personalized treatment, patient experience, medication tapering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication. https://app.cochat.ai/papers/10.1177/2045125320932452
The paper
Groot, P. C., & van Os, J. (2020). How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320932452

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.